COMBINED DRUG FOR DYSURIA TREATMENT

摘要

PROBLEM TO BE SOLVED: To provide a dysuria therapeutic combined drug capable of enhancing the dysuria therapeutic effect of an anticholinergic pollakiuria therapeutic drug while improving side effects such as dry mouth.;SOLUTION: The present invention consists of a combination of a GIRK channel inhibitor and an anticholinergic pollakiuria therapeutic drug in a compounding dose that does not show effect as each single agent. The invention is also characterized by that the compounding dose of a GIRK channel inhibitor is 10-200 mg per day, the compounding dose of an anticholinergic pollakiuria therapeutic drug is 0.01-6 mg per day, and the GIRK channel inhibitor consists of one or more combination selected from tipepidine, noscapine, dextromethorphan, cloperastine, and pentoxyverine, and the like.;SELECTED DRAWING: None;COPYRIGHT: (C)2018,JPO&INPIT